MRRCF - Wayland Group Corp.
| Previous Close | 0.2926 |
| Open | 0.2710 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.2400 - 0.2848 |
| 52 Week Range | 0.2400 - 2.0400 |
| Volume | 104,123 |
| Avg. Volume | 90,292 |
| Market Cap | 47.938M |
| Beta (3Y Monthly) | 0.43 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.2650 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Benzinga•11 days ago
From Coffee To Cannabis: Colombian Legislators To Move For Adult-Use Legalization
This is the first of a two-part series on the history of Colombia and its route to cannabis legalization. Colombia is in an extraordinary position. It possesses the fourth largest economy in Latin America.
- GlobeNewswire•2 months ago
Wayland Group Closes Transaction with ICC International Cannabis Corp.
Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to announce that the Company has completed a transaction relating to the sale of a 49.9% interest in Maricann B.V. (“Wayland International”), to ICC International Cannabis Corp. (WRLD-U.CN) (8K51.F) (KNHBF) (“ICC”) pursuant to the terms of an amended and restated transaction agreement and related subscription agreement. Wayland now beneficially owns approximately 246,614,000 shares of ICC representing approximately 37% of the outstanding ICC shares following closing on a fully diluted basis. Under the terms of the agreement, ICC is expected to subsequently acquire a 49.9% interest in the balance of Wayland’s international portfolio of assets and, upon completion of that acquisition, Wayland would beneficially own an aggregate of 300,000,000 ICC shares, representing an ownership interest in ICC of approximately 41.7%.
- GlobeNewswire•2 months ago
Wayland Group provides Clarification on ICC Transaction
The Company understands that ICC International Cannabis Corp. will retract the erroneous announcement on this subject that was made early today. Wayland is a vertically integrated cultivator and processor of cannabis.
- GlobeNewswire•2 months ago
Wayland Group Confirms “BfARM” award for German Cannabis production
DEMECAN is awarded three lots of thirteen total, which makes DEMECAN one of three companies globally to achieve a cannabis license for domestic production in Germany, out of 79 applicants. DEMECAN will now begin production within Wayland’s Ebersbach facility, following completion of upgrades to quality and security systems. Additionally, Wayland GmbH has received its narcotics license from the Bundesopiumstelle, the narcotics division of BfArM.
- Market Realist•2 months ago
How Does Planet 13’s Valuation Multiple Compare with Peers?
Why Planet 13 Stock Fell ~6.8% on May 7(Continued from Prior Part)Valuation multipleThe increase in Planet 13 Holdings (PLTH) (PLNHF) stock price since the beginning of 2019 has led to a rise in its valuation multiple. As of May 7, the company was
- GlobeNewswire•3 months ago
Wayland Addresses Transaction with ICC International Cannabis Corp.
Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) confirms that any failure-to-file cease trade order (“FFCTO”) derived from the Company’s delay in annual filings will not materially affect the Company’s sale of a 49.9% interest in its international asset and license portfolio to ICC International Cannabis Corp (the “Transaction”). Wayland is of the opinion that the Company’s delay in annual filings will not impede closing timeline of the Transaction. Wayland is a vertically integrated cultivator and processor of cannabis.
- GlobeNewswire•3 months ago
Wayland Group Confirms Delay in Annual Filings; Expects Issuance of Cease Trade Order
Wayland Group Corp. (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) announced today that it will be delayed in filing its audited annual financial statements for the year ended December 31, 2018, the related management’s discussion and analysis and certificates of its CEO and CFO (collectively, the “Required Filings”) with Canadian securities regulators until after today’s filing deadline. The additional time is required to permit the Company and its auditors, MNP LLP, to complete work and enquiries in connection with the audit of the Company’s 2018 financial statements. The Company and its advisors are working diligently to complete such work and enquiries and the Company intends to make the Required Filings as soon as possible.
- GlobeNewswire•3 months ago
Wayland Group Announces Anticipated Delay in Annual Filings
Wayland Group Corp. (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) announced today that it anticipates a delay in filing its audited annual financial statements for the year ended December 31, 2018, the related management’s discussion and analysis and certificates of its CEO and CFO (collectively, the “Required Filings”) with Canadian securities regulators until after the April 30, 2019 filing deadline. The additional time is required to permit the Company’s auditors, MNP LLP, to complete its review and enquiries in connection with the audit of the Company’s 2018 financial statements. The Company and its auditors are working diligently, and the Company intends to make the Required Filings as soon as possible and it expects to make these filings by no later than June 14, 2019.
- GlobeNewswire•3 months ago
REPEAT - Wayland Group Signs Definitive Agreement with ICC International Cannabis Corp. to Sell 49.9% of International Business
Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to announce that the Company has signed a definitive agreement to sell a 49.9% interest in Wayland’s international portfolio of assets to ICC International Cannabis Corp. (CSE:WRLD.u) (8K51.F) (WLDCF) (“ICC”). The terms of the definitive agreement are consistent with the Letter of Intent that was announced on January 15, 2019. Wayland will receive 300,000,000 shares of ICC under the agreement, representing approximately 35% of the current outstanding ICC shares on a fully diluted basis. Wayland is also pleased to announce that Matthew McLeod, the current General Counsel and Vice President Operations and Compliance, has been appointed as President effective immediately.
- GlobeNewswire•3 months ago
REPEAT - International Cannabis Signs Definitive Agreement to Acquire 49.9% of International Asset and Licence Portfolio From Wayland Group
ICC International Cannabis Corp. (CSE:WRLD.U)(8K51.F)(WLDCF) ("ICC" or “International Cannabis” the “Company”) is pleased to announce that the Company has signed a definitive agreement to acquire 49.9% of Wayland Group Corp.’s (CSE:WAYL)(75M.F)(MRRCF) (“Wayland”) international asset and license portfolio. Under the terms of the definitive agreement, International Cannabis will issue Wayland 300,000,000 shares in the capital of ICC, representing approximately 38% of the current outstanding ICC shares on a fully diluted basis.
- GlobeNewswire•3 months ago
Wayland Group Signs Definitive Agreement with ICC International Cannabis Corp. to Sell 49.9% of International Business
Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to announce that the Company has signed a definitive agreement to sell a 49.9% interest in Wayland’s international portfolio of assets to ICC International Cannabis Corp. (CSE:WRLD.u) (8K51.F) (WLDCF) (“ICC”). The terms of the definitive agreement are consistent with the Letter of Intent that was announced on January 15, 2019. Wayland will receive 300,000,000 shares of ICC under the agreement, representing approximately 35% of the current outstanding ICC shares on a fully diluted basis. Wayland is also pleased to announce that Matthew McLeod, the current General Counsel and Vice President Operations and Compliance, has been appointed as President effective immediately.
- GlobeNewswire•3 months ago
International Cannabis Signs Definitive Agreement to Acquire 49.9% of International Asset and Licence Portfolio From Wayland Group
ICC International Cannabis Corp. (CSE:WRLD.U)(8K51.F)(WLDCF) ("ICC" or “International Cannabis” the “Company”) is pleased to announce that the Company has signed a definitive agreement to acquire 49.9% of Wayland Group Corp.’s (CSE:WAYL)(75M.F)(MRRCF) (“Wayland”) international asset and license portfolio. Under the terms of the definitive agreement, International Cannabis will issue Wayland 300,000,000 shares in the capital of ICC, representing approximately 38% of the current outstanding ICC shares on a fully diluted basis.
- GlobeNewswire•3 months ago
Wayland Provides Clarification on Recent German Tender Update
Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) would like to expand on the update that the Company provided to the market on April 17, 2019 with respect to the ongoing process for domestic cultivation of medical cannabis in Germany (“the Update”). The Company would like to clarify that Wayland’s joint venture with DEMECAN GmbH (“DEMECAN”) received a score of 60/60 for quality and 40/40 for pricing in the original tender process from early in 2018. Notwithstanding the challenge to the most current tenders described in the Update, the Company is confident that DEMECAN will be successful, and will be awarded the 3 lots for production.
- GlobeNewswire•3 months ago
Wayland Provides Update on German Tender Process
Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) would like to address recent reports in the media about the selection process in Germany for domestic medical cannabis cultivation. Wayland, through its joint venture with DEMECAN GmbH (“DEMECAN”), was originally selected by BfArM to receive three licenses to produce medical cannabis in Germany. Wayland’s quality concept received 60 out of 60 points for quality and 40 out of 40 points for price.
- Market Realist•3 months ago
How Does MedMen’s Valuation Multiple Compare with Its Peers?
MedMen Announces Preliminary Q3 Revenues(Continued from Prior Part)Valuation multipleSince the beginning of 2019, MedMen Enterprises (MMEN) (MMNFF) has fallen by 3.6% as of April 12. The decline in MedMen’s stock price has also lowered its
- Market Realist•3 months ago
MedMen Announces Preliminary Q3 Revenues
MedMen Announces Preliminary Q3 RevenuesThird-quarter performance Today, MedMen Enterprises (MMEN) (MMNFF) posted an unaudited revenue of $36.60 million for the third quarter of fiscal 2019, which ended on March 30, 2019. Year-over-year, the
- GlobeNewswire•3 months ago
Wayland Group Announces Facility Drawdown
TORONTO, April 12, 2019 -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) today announced that it has completed the drawdown of the fifth.
- ACCESSWIRE•3 months ago
Wayland Group is Expanding, Questions, Catalysts, and Hurdles Every Marijuana Stock Investor Should be Considering
NEW YORK, NY / ACCESSWIRE / April 11, 2019 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on Wayland Group Corp. (MRRCF), a vertically integrated cultivator and processor of cannabis. The Company was founded in 2013 and is based in Burlington, Ontario, Canada and Munich, Germany, with production facilities in Langton, Ontario where it operates a cannabis cultivation, extraction, formulation, and distribution business under federal licenses from the Government of Canada. Traders News Source has created a comprehensive report on the current state of the cannabis market, including an outlook on where the industry may be headed in 2019.
- GlobeNewswire•3 months ago
Wayland Group Announces Changes to the Board of Directors
Wayland Group Corp. (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) announces the following change to its Board of Directors. Due to personal reasons, Rudi Hilti has resigned as Director of Wayland Group Corp. Mr. Hilti’s responsibilities at his own commercial and non-commercial enterprises have increased to a level that would compromise his time and effectiveness as a board member of the Company. Wayland would like to thank Rudi for his contributions to the Company and wishes him well in his future endeavors.
- Market Realist•3 months ago
Planet 13 and Wayland Group Posted Strong Performance Last Week
Planet 13 and Wayland Group Posted Strong Performance Last WeekSector performance Last week, the Horizons Marijuana Life Sciences ETF (HMMJ) and the ETFMG Alternative Harvest ETF (MJ) delivered positive returns. Between March 29 and April 5, HMMJ and
- GlobeNewswire•4 months ago
Wayland Selected as One of Three Groups, Pending Review Period, for Cannabis Production Licenses in Germany
Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is excited to announce that the Company has been selected by the German Federal Institute for Drugs and Medical Devices (“BfArM”), through its German joint venture DEMECAN GmbH, to begin domestic production of medical cannabis for the rapidly growing German patient population. The Company is one of three groups that have been selected and is subject to a review period, after which a final decision will be made no earlier than April 17, 2019. From the beginning, the market opportunity for medical cannabis in Germany has been a key part of Wayland’s global growth strategy.
- Market Realist•4 months ago
Trulieve Cannabis Opens Its 24th Dispensary in Florida
Trulieve Cannabis Opens Its 24th Dispensary in FloridaNew dispensary opens todayToday, Trulieve Cannabis (TRUL) (TCNNF) is opening a new dispensary in Clearwater, Florida. Apart from this dispensary, the company operates 23 others in the state. As
- GlobeNewswire•4 months ago
REPEAT - International Cannabis and Wayland Confirm Intent to Finalize Transaction
VANCOUVER, British Columbia, March 11, 2019 -- ICC International Cannabis Corp. (CSE: WRLD.U)(FWB: 8K51)(OTC: WLDCF) ("ICC" or “International Cannabis” or the “Company”) is.
